share_log

Gelteq Appoints Matthew Jones as Head of Sports Performance

Gelteq Appoints Matthew Jones as Head of Sports Performance

Gelteq任命馬修·瓊斯爲體育表現負責人
GlobeNewswire ·  01/24 13:00

Leading internationally-experienced sports nutritionist joins the Company's growing team to expand its sports vertical

一位具有國際經驗的體育營養師加入公司不斷壯大的團隊,以拓展其體育領域。

NEW YORK, Jan. 24, 2025 (GLOBE NEWSWIRE) -- Gelteq Limited (NASDAQ: GELS) ("Gelteq" or the "Company"), a global biotechnology company that specializes in the formulation, development, and manufacturing of ingestible gel technology, announced today the appointment of Matthew Jones as Head of Sports Performance. He will oversee the growth, outreach, and customer strategy of Gelteq's sports vertical.

紐約,2025年1月24日(環球新聞)——Gelteq有限公司(納斯達克:GELS)("Gelteq"或"公司")是一家全球生物技術公司,專注於可食用凝膠技術的配方、開發和製造,今天宣佈任命Matthew Jones爲體育表現負責人。他將負責Gelteq體育領域的增長、外展和客戶策略。

"The sports industry is one of a number of key areas that Gelteq's unique formulation can pose a significant improvement to nutrient delivery over traditional methods," said Nathan Givoni, Co-Founder and CEO of Gelteq. "Matthew's pedigree aligns perfectly for this position with his global experience in high-level sports training and sports dietetics and we are excited to grow the adoption of our gel-based delivery platform in the sports vertical under his guidance."

Gelteq的聯合創始人兼首席執行官Nathan Givoni表示:"體育產業是Gelteq獨特配方可以顯著改善營養素傳遞的關鍵領域之一,超過傳統方法。"他說:"Matthew的背景與他在高水平體育訓練和體育飲食方面的全球經驗完全契合,我們很高興在他的指導下推進我們基於凝膠的交付平台在體育領域的應用。"

"I look forward to beginning this journey toward greater adoption of the gel-based platform for better nutrient and supplement absorption with a focus on sports clientele," Jones said. "I greatly enjoy simplifying complex nutrition science, and with Gelteq's unique platform, we have the opportunity to expand on important nutrition science while providing a solution to help athletes improve their nutrition with a better delivery system."

Jones表示:"我期待着開始這段旅程,以更好地促進基於凝膠的平台的應用,以改善體育客戶的營養和補充品吸收。"他說:"我非常喜歡簡化複雜的營養科學,憑藉Gelteq獨特的平台,我們有機會擴展重要的營養科學,同時提供解決方案,幫助運動員通過更好的交付系統改善他們的營養。"

Mr. Jones is a leading internationally-experienced sports dietitian who currently works as Head of Nutrition with the United Arab Emirates Football Association and as a consultant to the Boston Celtics in the National Basketball Association. He has more than 12 years of applied experience in elite sports, having worked in international football, the English Premier League, the Women's Super League, and NCAA Division I sports. Jones holds a Master's Degree in Nutrition Science from University of Chester and is registered with the British Dietetic Association, Sport Nutrition Register.

Jones先生是一位領先的具有國際經驗的體育飲食師,目前擔任阿拉伯聯合酋長國足球協會的營養主管,並作爲波士頓凱爾特人隊的顧問,參與國家籃球協會。他在精英運動中擁有超過12年的實際經驗,曾在國際足球、英超聯賽、女子超級聯賽和NCAA第一分區體育中工作。Jones擁有切斯特大學營養科學碩士學位,並在英國飲食學會和體育營養註冊委員會註冊。

About Gelteq Limited:
Headquartered in Melbourne, Australia, Gelteq (NASDAQ: GELS) is a global biotechnology company focused on developing and commercializing white label gel-based delivery solutions for prescription drugs, nutraceuticals, pet care, and other products. Gelteq advances and commercializes its delivery solutions within five core verticals: pharmaceuticals, over-the-counter medications, nutraceuticals, animal medications, and sports nutrition. The Company's unique formulation directly addresses the issues associated with traditional drug delivery methods such as difficulty swallowing, taste of unpalatable ingredients, and dosage control. For more information, visit .

關於Gelteq有限公司:
Gelteq(納斯達克:GELS)總部位於澳洲墨爾本,是一家全球生物技術公司,專注於開發和商業化針對處方藥、保健品、寵物護理和其他產品的白標膠基傳遞解決方案。Gelteq在五個核心領域推進並商業化其傳遞解決方案:製藥、非處方藥、保健品、動物藥物和體育營養。該公司的獨特配方直接解決了傳統藥物傳遞方法中存在的問題,如吞嚥困難、令人不快的成分味道以及劑量控制。欲了解更多信息,請訪問 .

Forward-Looking Statements
Certain statements in this press release may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, contained in this press release are forward-looking statements. Forward-looking statements contained in this press release may be identified by the use of words such as "anticipate," "believe," "contemplate," "could," "estimate," "expect," "intend," "seek," "may," "might," "plan," "potential," "predict," "project," "suggest," "target," "aim," "should," "will," "would," or the negative of these words or other similar expressions, although not all forward-looking statements contain these words. Forward-looking statements are based on Gelteq's current expectations and are subject to inherent uncertainties, risks and assumptions that are difficult to predict, including risks related to the timing and fulfilment of current and future orders relating to Gelteq's products, the success of new programs, the ability to implement a new strategic plan and the success of a new strategic plan. Further, certain forward-looking statements are based on assumptions as to future events that may not prove to be accurate. For a further discussion of risks and uncertainties that could cause actual results to differ from those expressed in these forward-looking statements, as well as risks relating to the business of Gelteq in general, see the risk factors in the Annual Report on 20-F filed on November 15, 2024. All such forward-looking statements speak only as of the date they are made, and Gelteq undertakes no obligation to update or revise these statements, whether as a result of new information, future events or otherwise.

前瞻性聲明
本新聞稿中的某些聲明可能構成1995年《私人證券訴訟改革法案》意義上的「前瞻性聲明」。本新聞稿中包含的所有聲明,除了歷史事實聲明外,均爲前瞻性聲明。本新聞稿中的前瞻性聲明可通過使用如「預期」、「相信」、「考慮」、「可能」、「估計」、「期望」、「意圖」、「尋求」、「可能」、「計劃」、「潛在」、「預測」、「項目」、「建議」、「目標」、「瞄準」、「應該」、「將」、「會」或這些詞的否定形式或其他類似表達來識別,儘管並非所有前瞻性聲明都包含這些詞。前瞻性聲明是基於Gelteq當前的預期,並受難以預測的固有不確定性、風險和假設的影響,這些因素包括與Gelteq產品相關的當前和未來訂單的時間和履行的風險、新項目的成功、實施新戰略計劃的能力以及新戰略計劃的成功。此外,某些前瞻性聲明基於對未來事件的假設,而這些事件可能並不準確。有關可能導致實際結果與這些前瞻性聲明中所表達的不相符的風險和不確定性,以及與Gelteq業務一般相關的風險的進一步討論,請參見2024年11月15日提交的20-F年度報告中的風險因素。所有這些前瞻性聲明僅在作出之日有效,Gelteq不承擔任何更新或修訂這些聲明的義務,無論是因爲新信息、未來事件還是其他原因。

Contact:
CORE IR
516-222-2560
PR@gelteq.com

聯繫:
核心投資者關係
516-222-2560
PR@gelteq.com


譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
評論 評論 · 瀏覽 221

熱點推薦

搶先評論

聲明

本頁的譯文內容由軟件翻譯。富途將竭力但卻不能保證翻譯內容之準確和可靠,亦不會承擔因任何不準確或遺漏而引起的任何損失或損害。